Cargando…

First-degree family history of prostate cancer is associated the risk of breast cancer and ovarian cancer

The evidence for associations between family history of prostate cancer and the risk of breast cancer and ovarian cancer is inconclusive. The first systematic review and meta-analysis of studies was conducted to assess the risk of breast cancer and ovarian cancer associated with a family history of...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, QiongFei, Ying, Qinli, Ren, ZhengJu, Zhang, Qin, Lu, DongLiang, Wang, HongBai, Wei, WuRan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2021
Materias:	5700
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10545021/ https://www.ncbi.nlm.nih.gov/pubmed/33530178 http://dx.doi.org/10.1097/MD.0000000000023816

Ejemplares similares

Breast cancer knowledge in Lebanese females with positive family history
por: El Maouchi, Paul, et al.
Publicado: (2023)

Gene expression and prognosis of sirtuin family members in ovarian cancer
por: Zeng, Zhenguo, et al.
Publicado: (2020)

Diagnostic accuracy of DWI in patients with ovarian cancer: A meta-analysis
por: Yuan, Xia, et al.
Publicado: (2017)

First-degree family history of breast cancer is associated with prostate cancer risk: a systematic review and meta-analysis
por: Ren, Zheng-Ju, et al.
Publicado: (2019)

Increased expression of miR-153 predicts poor prognosis for patients with prostate cancer
por: Bi, Cheng-wei, et al.
Publicado: (2019)

Clinical characteristics and survival outcomes of patients with both primary breast cancer and primary ovarian cancer
por: Chen, Chang, et al.
Publicado: (2020)

Association of long-chain non-coding RNA GAS5 gene polymorphisms with prostate cancer risk and prognosis in Chinese Han population
por: Zhao, Lisha, et al.
Publicado: (2020)

The value of red cell distribution width in patients with ovarian cancer
por: Qin, Yuanyuan, et al.
Publicado: (2017)

Association between C-reactive protein level and subsequent risk of ovarian cancer: A meta-analysis of 13 cohorts in 1,852 ovarian cancer patients
por: Wang, Yan, et al.
Publicado: (2020)

STROBE-compliant integrin through focal adhesion involve in cancer stem cell and multidrug resistance of ovarian cancer
por: Wei, Luwei, et al.
Publicado: (2017)

Clinicopathological and prognostic significance of circRNAs in lung cancer: A systematic review and meta-analysis
por: Zheng, Yuxuan, et al.
Publicado: (2021)

Long non-coding RNA small nucleolar RNA host gene 7 expression level in prostate cancer tissues predicts the prognosis of patients with prostate cancer
por: Xia, Qier, et al.
Publicado: (2020)

Third-line chemotherapy in advanced gastric cancer: A systematic review and meta-analysis
por: Zheng, Yu, et al.
Publicado: (2017)

Analysis of preoperative blood platelet parameters in terms of diversity of epithelial ovarian cancer
por: Bednarska, Katarzyna, et al.
Publicado: (2018)

Successful treatment of ovarian cancer with apatinib combined with chemotherapy: A case report
por: Zhang, Mingzi, et al.
Publicado: (2017)

Clinicopathological characteristics and outcomes of metachronous rectal cancer in patients with a history of cervical cancer with and without remote radiotherapy: Reports of 45 cases
por: Hung, Hsinyuan, et al.
Publicado: (2020)

Hyperthermic intraperitoneal chemotherapy combined with systemic chemotherapy for gastric cancer peritoneal carcinomatosis: A protocol for systematic review and meta-analysis of randomized controlled trials
por: Lu, Yidan, et al.
Publicado: (2020)

Association of finasteride with prostate cancer: A systematic review and meta-analysis
por: Wang, Lei, et al.
Publicado: (2020)

Medication utilization evaluation of androgen deprivation therapy for prostate cancer in Taiwan
por: Liao, Kuang-Ming, et al.
Publicado: (2020)

Comparing effectiveness of radical prostatectomy versus external beam radiotherapy in patients with locally advanced prostate cancer: A population-based analysis
por: Zhou, Xianghong, et al.
Publicado: (2020)

Incidence of venous thromboembolism following the neoadjuvant chemotherapy regimen for epithelial type of ovarian cancer
por: Chavan, Devendra Manik, et al.
Publicado: (2017)

C-reactive protein and risk of ovarian cancer: A systematic review and meta-analysis
por: Li, Jing, et al.
Publicado: (2017)

Ovarian metastasis from breast cancer in three Chinese females: Three case reports
por: Wang, Jiang, et al.
Publicado: (2019)

The effect of folate intake on ovarian cancer risk: A meta-analysis of observational studies
por: Wang, Kena, et al.
Publicado: (2021)

The clinical validity of miR-126 as a prognostic marker in epithelial ovarian cancer
por: Liu, Lin, et al.
Publicado: (2023)

Establishment and assessment of a nomogram for predicting prognosis in bone-metastatic prostate cancer
por: Liu, Wenfei, et al.
Publicado: (2023)

Prognostic value of cell division cycle-associated protein-3 in prostate cancer
por: Gu, Peng, et al.
Publicado: (2023)

Potential roles of tumor microenvironment in gefitinib-resistant non-small cell lung cancer: A narrative review
por: Chen, Mu-Tong, et al.
Publicado: (2023)

Radical radiotherapy for cervical cancer and meningioma with a history of Guillain-Barré syndrome: A case report
por: Deng, Kangli, et al.
Publicado: (2022)

Laparoscopic advanced intraoperative restaging for radiographic non-metastasis pancreatic cancer: Protocol for a single-center, cross-sectional and follow-up study
por: Zheng, Zhi, et al.
Publicado: (2020)

Metastatic castration-resistant prostate cancer: Academic insights and perspectives through bibliometric analysis
por: He, Lugeng, et al.
Publicado: (2020)

Clinicopathological characteristics and survival outcomes in neuroendocrine prostate cancer: A population-based study
por: Zhu, Jiamin, et al.
Publicado: (2021)

Treating the primary in low burden metastatic prostate cancer: Where do we stand?
por: Luo, Hua-Chun, et al.
Publicado: (2020)

The impact of body mass index on prostate cancer: An updated systematic review and meta-analysis
por: Tzenios, Nikolaos, et al.
Publicado: (2022)

Plumbagin-loaded aptamer-targeted poly d,l-lactic-co-glycolic acid-b-polyethylene glycol nanoparticles for prostate cancer therapy
por: Pan, Minjie, et al.
Publicado: (2017)

Immunosenescence and cancer: Opportunities and challenges
por: Fu, Zhibin, et al.
Publicado: (2023)

Long-term cancer-related fatigue outcomes in patients with locally advanced prostate cancer after intensity-modulated radiotherapy combined with hormonal therapy
por: Luo, Hua-Chun, et al.
Publicado: (2016)

Prognostic Value of KIF2A and HER2-Neu Overexpression in Patients With Epithelial Ovarian Cancer
por: Wang, Di, et al.
Publicado: (2016)

Prognostic significance of preoperative prognostic nutritional index in ovarian cancer: A systematic review and meta-analysis
por: Dai, Yan, et al.
Publicado: (2020)

Efficacy of cisplatin combined with vinorelbine as second- or higher-line palliative chemotherapy in patients with advanced ovarian cancer
por: Yeon, Sang Hoon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_06e9d9qttld19i87gitf95k4ek